Conversely, miR-193a-3p inhibition promoted tumorigenic effect, which could be diminished by S6K2 knock-down, suggesting that miR-193a-3p has a role in tumor suppression in NSCLC through the targeting of S6K2. The gene discussed is RPS6KB2; the disease is non-small cell lung carcinoma.